GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psomagen Inc (XKRX:950200) » Definitions » Institutional Ownership

Psomagen (XKRX:950200) Institutional Ownership : 0.06% (As of Jun. 07, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Psomagen Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Psomagen's institutional ownership is 0.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Psomagen's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Psomagen's Float Percentage Of Total Shares Outstanding is 0.00%.


Psomagen Institutional Ownership Historical Data

The historical data trend for Psomagen's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psomagen Institutional Ownership Chart

Psomagen Historical Data

The historical data trend for Psomagen can be seen below:

2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30 2021-12-31 2022-02-28 2022-03-31
Institutional Ownership 1.11 1.11 1.11 1.11 1.11 0.06 0.06 0.06 0.06 0.06

Psomagen Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Psomagen (XKRX:950200) Business Description

Traded in Other Exchanges
N/A
Address
1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850
Psomagen Inc, formerly Macrogen Corp provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Psomagen (XKRX:950200) Headlines

No Headlines